A Phase 2 Study of (99m)Tc-Tilmanocept in the Detection of Sentinel Lymph Nodes in Melanoma and Breast Cancer

BACKGROUND: Several (99m)Tc-labeled agents that are not approved by the U.S. Food and Drug Administration are used for lymphatic mapping. A new low-molecular-weight mannose receptor–based, reticuloendothelial cell-directed, (99m)Tc-labeled lymphatic imaging agent, (99m)Tc-tilmano-cept, was used for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Leong, Stanley P. L., Kim, Julian, Ross, Merrick, Faries, Mark, Scoggins, Charles R., Rich Metz, Wendy L., Cope, Frederick O., Orahood, Richard C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3071527/
https://ncbi.nlm.nih.gov/pubmed/21331809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-010-1524-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados